Literature DB >> 9672241

The Na+/I- symporter (NIS): recent advances.

O Levy1, A De la Vieja, N Carrasco.   

Abstract

The Na+/I- symporter (NIS) catalyzes the accumulation of iodide into thyroid cells, an essential step in the biosynthesis of thyroid hormones. As a result of the isolation of the rat NIS cDNA, steadfast advances in the study of NIS at the molecular level have resulted in the following accomplishments: generation of high-affinity anti-NIS antibodies, elucidation of NIS stoichiometry and specificity by electrophysiological analysis, biochemical and immunological experimental testing of the proposed NIS secondary structure model, monitoring the regulation of NIS protein expression by thyroid stimulating hormone and iodide, characterization of the rat NIS gene promoter, isolation of the cDNA clone encoding human NIS and subsequent determination of human NIS genomic organization, description of NIS mutations in patients with congenital lack of iodide transport, and the molecular identification of NIS in extrathyroidal tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9672241     DOI: 10.1023/a:1020577426732

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  28 in total

1.  Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na+/I- symporter gene.

Authors:  T Endo; M Kaneshige; M Nakazato; M Ohmori; N Harii; T Onaya
Journal:  Mol Endocrinol       Date:  1997-10

2.  Promoter characterization of the rat Na+/I- symporter gene.

Authors:  Q Tong; K Y Ryu; S M Jhiang
Journal:  Biochem Biophys Res Commun       Date:  1997-10-09       Impact factor: 3.575

3.  Iodine deficiency and brain development.

Authors:  P Stubbe; F J Schulte; P Heidemann
Journal:  Bibl Nutr Dieta       Date:  1986

4.  Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. Relationship between its expression and activity.

Authors:  A Paire; F Bernier-Valentin; S Selmi-Ruby; B Rousset
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

5.  Na(+)-I- symport activity is present in membrane vesicles from thyrotropin-deprived non-I(-)-transporting cultured thyroid cells.

Authors:  S M Kaminsky; O Levy; C Salvador; G Dai; N Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Membrane topology of the human Na+/glucose cotransporter SGLT1.

Authors:  E Turk; C J Kerner; M P Lostao; E M Wright
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

Review 7.  Iodide transport in the thyroid gland.

Authors:  N Carrasco
Journal:  Biochim Biophys Acta       Date:  1993-06-08

8.  Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells.

Authors:  T Kogai; T Endo; T Saito; A Miyazaki; A Kawaguchi; T Onaya
Journal:  Endocrinology       Date:  1997-06       Impact factor: 4.736

9.  Hypothyroidism in a Brazilian kindred due to iodide trapping defect caused by a homozygous mutation in the sodium/iodide symporter gene.

Authors:  J Pohlenz; G Medeiros-Neto; J L Gross; S P Silveiro; M Knobel; S Refetoff
Journal:  Biochem Biophys Res Commun       Date:  1997-11-17       Impact factor: 3.575

10.  A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect.

Authors:  A Matsuda; S Kosugi
Journal:  J Clin Endocrinol Metab       Date:  1997-12       Impact factor: 5.958

View more
  12 in total

Review 1.  Regulation of sodium/iodide symporter.

Authors:  S M Jhiang
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.

Authors:  P Agretti; A Dimida; G De Marco; E Ferrarini; J C Rodrìguez Gonzàlez; F Santini; P Vitti; A Pinchera; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2010-05-17       Impact factor: 4.256

Review 3.  The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.

Authors:  Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

4.  High dose of radioactive iodine per se has no effect on glucose metabolism in thyroidectomized rats.

Authors:  Roghaieh Samadi; Mahboubeh Ghanbari; Babak Shafiei; Sevda Gheibi; Fereidoun Azizi; Asghar Ghasemi
Journal:  Endocrine       Date:  2017-03-10       Impact factor: 3.633

Review 5.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 6.  Genetics and phenomics of hypothyroidism and goiter due to NIS mutations.

Authors:  Christine Spitzweg; John C Morris
Journal:  Mol Cell Endocrinol       Date:  2010-02-12       Impact factor: 4.102

Review 7.  Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer.

Authors:  Chao Ma; Jiawei Xie; Zhongxin Jiang; Guoming Wang; Shuyao Zuo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-04       Impact factor: 9.236

Review 8.  [The sodium-iodide symporter. Pathophysiologic, diagnostic and therapeutic significance].

Authors:  C Spitzweg
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

9.  Morphometric and functional changes of salivary gland dysfunction after radioactive iodine ablation in a murine model.

Authors:  Jeong-Seok Choi; In Suh Park; Seok-Ki Kim; Jae-Yol Lim; Young-Mo Kim
Journal:  Thyroid       Date:  2013-07-25       Impact factor: 6.568

10.  Radioprotective Effect of Epigallocatechin-3-Gallate on Salivary Gland Dysfunction After Radioiodine Ablation in a Murine Model.

Authors:  Jeong-Seok Choi; Hye-Young An; In Suh Park; Seok-Ki Kim; Young-Mo Kim; Jae-Yol Lim
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-05-03       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.